Cefepime versus Ceftriaxone for Empiric Treatment of Hospitalized Patients with Community-Acquired Pneumonia

We read with interest the report of the clinical trial by Zervos et al. (5) in which cefepime was compared with ceftriaxone for empiric treatment of hospitalized patients with community-acquired pneumonia. Although that paper presented some interesting findings, there are several methodological flaws with the study that we would like to comment on.